Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis
Crossref DOI link: https://doi.org/10.1186/s40545-016-0065-7
Published Online: 2016-05-02
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Newman, Charles
Ajay, Vamadevan S.
Srinivas, Ravi
Bhalla, Sandeep
Prabhakaran, Dorairaj
Banerjee, Amitava
Funding for this research was provided by:
European Research Council (339239)